Trial Profile
A Randomized, Double-blind, Controlled Clinical Study of GB-0998 for the Steroid-resistant Polymyositis and Dermatomyositis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Dec 2021
Price :
$35
*
At a glance
- Drugs Immunoglobulin G (Primary)
- Indications Dermatomyositis; Polymyositis
- Focus Therapeutic Use
- 24 Dec 2014 New trial record